Implant project against glaucoma.
EyeD Pharma has raised €45M across 1 funding round, most recently a round in Dec 2021. Based in Liege, Belgium; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-22 | Other | €45M |
| — |
| View deal → |
